Report overview
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
This report contains market size and forecasts of Asthma Drugs in global, including the following market information:
Global Asthma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Asthma Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Asthma Drugs companies in 2021 (%)
The global Asthma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Quick-relief Medications (Rescue Medications) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Asthma Drugs include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Asthma Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Asthma Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Drugs Market Segment Percentages, by Type, 2021 (%)
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Global Asthma Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Drugs Market Segment Percentages, by Application, 2021 (%)
Allergic Asthma
Non-Allergic Asthma
Global Asthma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Asthma Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Asthma Drugs revenues share in global market, 2021 (%)
Key companies Asthma Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Asthma Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
